SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-20-000040
Filing Date
2020-03-18
Accepted
2020-03-18 16:14:34
Documents
16
Period of Report
2020-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20191231-8ker.htm   iXBRL 8-K 41921
2 EXHIBIT 99.1 a20191231-8kex991.htm EX-99.1 105965
8 logo.jpg GRAPHIC 4821
  Complete submission text file 0000819050-20-000040.txt   312065

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200318.xsd EX-101.SCH 4436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200318_cal.xml EX-101.CAL 617
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200318_def.xml EX-101.DEF 1467
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200318_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200318_pre.xml EX-101.PRE 14107
15 EXTRACTED XBRL INSTANCE DOCUMENT a20191231-8ker_htm.xml XML 4572
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 20724687
SIC: 2836 Biological Products, (No Diagnostic Substances)